These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34829722)

  • 1. Immunomodulation and Antioxidant Activities as Possible Trypanocidal and Cardioprotective Mechanisms of Major Terpenes from
    Espinel-Mesa DX; González Rugeles CI; Mantilla Hernández JC; Stashenko EE; Villegas-Lanau CA; Quimbaya Ramírez JJ; García Sánchez LT
    Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).
    Moreno ÉM; Leal SM; Stashenko EE; García LT
    BMC Complement Altern Med; 2018 Jul; 18(1):225. PubMed ID: 30053848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory, trypanocide, and antioxidant properties of essential oil fractions of Lippia alba (Verbenaceae).
    Quintero WL; Moreno EM; Pinto SML; Sanabria SM; Stashenko E; García LT
    BMC Complement Med Ther; 2021 Jul; 21(1):187. PubMed ID: 34215249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical composition and trypanocidal activity of volatile oils from Brazilian Caatinga plants.
    Oliveira de Souza LI; Bezzera-Silva PC; do Amaral Ferraz Navarro DM; da Silva AG; Dos Santos Correia MT; da Silva MV; de Figueiredo RCBQ
    Biomed Pharmacother; 2017 Dec; 96():1055-1064. PubMed ID: 29217159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lippia sidoides and Lippia origanoides essential oils affect the viability, motility and ultrastructure of Trypanosoma cruzi.
    de Melo ARB; Maciel Higino TM; da Rocha Oliveira ADP; Fontes A; da Silva DCN; de Castro MCAB; Dantas Lopes JA; de Figueiredo RCBQ
    Micron; 2020 Feb; 129():102781. PubMed ID: 31830667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy.
    Farani PSG; Begum K; Vilar-Pereira G; Pereira IR; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
    Front Cell Infect Microbiol; 2021; 11():692655. PubMed ID: 34381739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could phenothiazine-benznidazole combined chemotherapy be effective in controlling heart parasitism and acute infectious myocarditis?
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Pharmacol Res; 2020 Aug; 158():104907. PubMed ID: 32416214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury.
    Carvalho CM; Silverio JC; da Silva AA; Pereira IR; Coelho JM; Britto CC; Moreira OC; Marchevsky RS; Xavier SS; Gazzinelli RT; da Glória Bonecini-Almeida M; Lannes-Vieira J
    PLoS Negl Trop Dis; 2012; 6(5):e1644. PubMed ID: 22590660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.
    Vilar-Pereira G; Resende Pereira I; de Souza Ruivo LA; Cruz Moreira O; da Silva AA; Britto C; Lannes-Vieira J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4297-309. PubMed ID: 27161638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanocidal action of
    Baldissera MD; de Freitas Souza C; Mourão RHV; da Silva LVF; Monteiro SG
    J Parasit Dis; 2017 Jun; 41(2):345-351. PubMed ID: 28615837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity.
    Machado FS; Martins GA; Aliberti JC; Mestriner FL; Cunha FQ; Silva JS
    Circulation; 2000 Dec; 102(24):3003-8. PubMed ID: 11113053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Reyes PA; Vallejo M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004102. PubMed ID: 16235350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on in vitro activities of citral, limonene and essential oils from Lippia citriodora and L. alba on yellow fever virus.
    Gómez LA; Stashenko E; Ocazionez RE
    Nat Prod Commun; 2013 Feb; 8(2):249-52. PubMed ID: 23513741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.